Joseph P. Iaconis - Concepedia

Author

Joseph P. Iaconis

AstraZeneca (United States)

Also Known As

J P Iaconis, J. P. Iaconis, JOSEPH P. IACONIS, Joseph Iaconis, Joseph P. Iaconis

Publications

955

Citations

H-Index

Concepts

All Affiliations

AstraZeneca (United States)AstraZeneca (United Kingdom)Creighton University Wilmington University

About

Joseph P. Iaconis is an author at AstraZeneca (United States) specializing in medicine, clinical microbiology, and antibiotics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	500
2	Health Sciences	3	3	183
3	Biochemistry	1	1	84
4	Gastroenterology	1	1	55
5	Immunology	1	1	140

Joseph P. Iaconis

Publications

875

Citations

H-Index

Page 1

	Year	Citations
Immunization of adult hamsters against Clostridium difficile-associated ileocecitis and transfer of protection to infant hamsters P H Kim, Joseph P. Iaconis, Rial D. Rolfe Infection and Immunity VaccinationToxoid AVeterinary VaccineImmunizing ToxoidMicrobial Toxin	1987	140
Analysis of Staphylococcus aureus clinical isolates with reduced susceptibility to ceftaroline: an epidemiological and structural perspective Richard A. Alm, Robert E. McLaughlin, Veronica N. Kos, Journal of Antimicrobial Chemotherapy	2014	107
Ceftaroline fosamil versus ceftriaxone for the treatment of Asian patients with community-acquired pneumonia: a randomised, controlled, double-blind, phase 3, non-inferiority with nested superiority trial Nan Zhong, Tieying Sun, Chao Zhuo, The Lancet Infectious Diseases Community-acquired PneumoniaPulmonary CareAntibioticsNested Superiority TrialAsian Patients	2014	94
Resistance to ticarcillin-potassium clavulanate among clinical isolates of the family Enterobacteriaceae: role of PSE-1 beta-lactamase and high levels of TEM-1 and SHV-1 and problems with false susceptibility in disk diffusion tests Christine C. Sanders, Joseph P. Iaconis, Gerald P. Bodey, Antimicrobial Agents and Chemotherapy Antimicrobial Resistance GeneAntimicrobial SusceptibilityHealth SciencesAntibioticsEscherichia Coli Isolates	1988	87
Purification and characterization of inducible beta-lactamases in Aeromonas spp Joseph P. Iaconis, Christine C. Sanders Antimicrobial Agents and Chemotherapy Antimicrobial SusceptibilityHealth SciencesAntibioticsBiochemistryBacteriology	1990	84
A Phase III, randomized, controlled, non-inferiority trial of ceftaroline fosamil 600 mg every 8 h versus vancomycin plus aztreonam in patients with complicated skin and soft tissue infection with systemic inflammatory response or underlying comorbidities Matthew Dryden, Yingyuan Zhang, David J. Wilson, Journal of Antimicrobial Chemotherapy	2016	61
Intestinal colonization of infant hamsters with Clostridium difficile Rial D. Rolfe, Joseph P. Iaconis Infection and Immunity Intragastric AdministrationGastroenterologyPathologyToxicologyMicrobiology	1983	55
Meropenem: activity against resistant Gram-negative bacteria and interactions with -lactamases Christine C. Sanders, William E. Sanders, Kenneth S. Thomson, Journal of Antimicrobial Chemotherapy	1989	44
Convalescent phase outpatient parenteral antiinfective therapy for children with complicated appendicitis John S. Bradley, Carolyn E. Behrendt, Antonio Arrieta, The Pediatric Infectious Disease Journal	2001	35
Ceftaroline fosamil doses and breakpoints for<i>Staphylococcus aureus</i>in complicated skin and soft tissue infections Shampa Das, Jianguo Li, Joseph P. Iaconis, Journal of Antimicrobial Chemotherapy	2018	34

Page 1